ALISON STRATTON: Open Payments
NPI 1407638414 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,336 in 82 payments from 31 companies in 2025. Trend: 2023 $672 · 2024 $1,328 · 2025 $3,336
Food & beverage: $2,156Long term medical supply or device loan: $1,180
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $1,513 |
| Janssen Biotech, Inc. | 4 | $264 |
| Merck Sharp & Dohme LLC | 4 | $236 |
| E.R. Squibb & Sons, L.L.C. | 10 | $172 |
| Ipsen Biopharmaceuticals, Inc | 1 | $142 |
| PharmaEssentia USA Corporation | 1 | $125 |
| BeOne Medicines USA, Inc. | 1 | $121 |
| Daiichi Sankyo Inc. | 4 | $99 |
| ABBVIE INC. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
Products named: KISQALI, RYBREVANT, KEYTRUDA, Onivyde, OPDIVO, BESREMI, BRUKINSA, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
